Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SCHD vs GSK✓SelectedUSD · GSKSCHD vs GSK performance historyLatest closeAs of-1.73%11/18
Stock and ETF performance explorer

SCHD vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+62.5%
GSK return
+56.0%
Excess return
+6.5%
Maximum drawdown
-16.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.7%-1.3%-0.4%-1.5%
7D-3.7%-3.1%-0.5%-3.0%
30D+1.3%-0.9%+2.2%+1.5%
3M+1.4%-4.2%+5.5%+2.1%
6M+10.0%-1.6%+11.6%+10.2%
YTD+29.6%+2.6%+27.0%+28.4%
1Y+32.2%+6.2%+26.0%+30.1%
All+62.5%+56.0%+6.5%+45.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling